NCT00107861View on ClinicalTrials.gov

Interferon-Beta Gene Transfer (Ad.hIFN-β) as Treatment for Refractory Colorectal Carcinoma With Liver Metastases

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

May 31, 2005

Study Completion Date

September 30, 2006

Conditions
Colorectal CarcinomaMetastases
Interventions
DRUG

Ad.hIFN-β (BG00001, IDEC-201)

Trial Locations (2)

75201

Mary Crowley Medical Research Center, Dallas

92037

University of California San Diego, La Jolla

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY